Icon 30-Day Option Volume & Interest Snapshot Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology ...

Culper Research announced a short position in Zeta Global (ZETA), saying it believes the company has formed “two-way” contracts ...

Climate Action 15 profiles top founders, global activists, academics, and nonprofit and public-sector leaders tackling climate solutions.

A fundamental truth about change is that it’s rarely technology that’s the challenge, it’s the people. Here, The Audience ...

Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with ...

However, new Swedish research has found that they might not be needed for ... that's especially true for folks who have ...

Bitcoin reached a new high on the back of the election results. Find out whether that makes it a good time to buy.

WASHINGTON (Reuters) - The United States on Wednesday targeted Russia with fresh sanctions, issuing curbs on hundreds of ...

Federal law requires creditors to provide a detailed disclosure, also known as an adverse action letter. Learn more about what adverse action letters include and what steps to take if you receive ...

New data shows 13% of older people across the south of Scotland may lack proper nutrition which could result in illness. | ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast ...